about
A comprehensive intervention following the clinical pathway of eating and swallowing disorder in the elderly with dementia: historically controlled studyPersistent molecular remission of refractory acute myeloid leukemia with inv(16)(p13.1q22) in an elderly patient induced by cytarabine ocfosfate hydrate.Three cases of systemic amyloidosis successfully diagnosed by subcutaneous fat tissue biopsy of the hipAutopsy-Proven Intravascular Lymphoma Presenting as Rapidly Recurrent Strokes.Haploidentical hematopoietic stem cell transplantation to adults with hematologic malignancies: analysis of 66 cases at a single Japanese center.Evaluation of the risk of intercostal artery laceration during thoracentesis in elderly patients by using 3D-CT angiography.Isolated hyperkalemia associated with cyclosporine administration in allogeneic stem cell transplantation for renal cell carcinoma.Peripheral neuropathy associated with chronic natural killer cell lymphocytosis.Effect of combined therapy of danaparoid sodium and tranexamic acid on chronic disseminated intravascular coagulation associated with abdominal aortic aneurysm.A Case of Diffuse Large B-Cell Lymphoma Mimicking Primary Effusion Lymphoma-Like Lymphoma.Antithrombotic therapies for elderly patients: handling problems originating from their comorbiditiesImmunoglobulin preparations attenuate organ dysfunction and hemostatic abnormality by suppressing the production of cytokines in lipopolysaccharide-induced disseminated intravascular coagulation in ratsNo interplay between the pathways mediating coagulation and inflammation in tissue factor-induced disseminated intravascular coagulation in ratsExpression of annexin II in human atherosclerotic abdominal aortic aneurysmsBeneficial effects of urokinase on lipopolysaccharide-induced disseminated intravascular coagulation in rats: focus on organ function and endothelin levels[Comprehensive intervention for the management of elderly patients with aspiration pneumonia]Coagulation and fibrinolytic features in AL amyloidosis with abnormal bleeding and usefulness of tranexamic acidThe first reported case of acquired haemophilia A in which bleeding episodes were successfully treated via administration of a single-dose mixture of activated factor VIIa/X
P50
Q33909274-0C333516-A482-49D1-AA60-DEE035F6AE15Q35096486-27AE106C-3863-4038-ABE2-BEE1AAD48BADQ37167777-C6EB6CF6-CDB4-4019-B36F-6C0D7F39AB36Q39876684-F7761058-59E7-4570-B991-E2CAC8047510Q43100490-2615873B-636F-4DAB-9FAB-7DD2963CC61BQ43948639-4DE9BFF6-1EF7-42B7-8D49-A4350200E3D3Q46376557-D12CE7D5-CA39-4920-9B9A-BB43CC7DD358Q46454663-D75E7F79-BBF3-4C73-BC25-9D5CDCB81CD3Q46673950-8E0DF235-8ABB-457B-A663-AA57C260EA68Q47139319-725E6DE0-7C6B-4714-A517-D0789D7F23FBQ58751103-AA968D6E-DD94-461E-AEA3-1CC0E3CF30C8Q79817073-7CCF5409-82A1-45F7-A781-D1DDD9467D81Q80166227-583A2120-40AE-4E45-A59F-00CBEEED80C0Q81334471-92BD10EA-E6E4-41F3-8324-3DB60F8189DCQ81668343-45A0C3BE-5BEB-4044-88EF-BD424AE30788Q83541529-C4AF4C2E-9B11-4D1E-BF36-01F468D2C982Q92387496-F002C779-3BB8-43E3-BCF3-A0020890021CQ93121052-AE07F256-D8C4-4861-AE10-86DA2E0E7A4C
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Masahisa Arahata
@ast
Masahisa Arahata
@en
Masahisa Arahata
@es
Masahisa Arahata
@nl
Masahisa Arahata
@sl
type
label
Masahisa Arahata
@ast
Masahisa Arahata
@en
Masahisa Arahata
@es
Masahisa Arahata
@nl
Masahisa Arahata
@sl
prefLabel
Masahisa Arahata
@ast
Masahisa Arahata
@en
Masahisa Arahata
@es
Masahisa Arahata
@nl
Masahisa Arahata
@sl
P106
P1153
9249666500
P21
P31
P496
0000-0002-3759-0724
P569
2000-01-01T00:00:00Z